Candidate predictors comprised demographic and infertility characteristics, anti-Müllerian hormone (AMH), pictorial blood loss assessment chart (PBAC) score, hemoglobin, carbohydrate antigen 125 (CA125), uterine volume, dysmenorrhea severity, adenomyosis type, endometrial-myometrial junctional zone involvement, and pretreatment modality. The gene discussed is AMH; the disease is Infertility.